Prevention of early postmenopausal bone loss by strontium ranelate: the randomized, two-year, double-masked, dose-ranging, placebo-controlled PREVOS trial. - Reginster,J.Y.; Deroisy,R.; Dougados,M. (Osteoporos Int, 2002)